Maravai Life Sciences

San Diego, United States Founded: 2014 • Age: 12 yrs
Provides enabling tools and services in the life sciences research and bio-production industries
Request Access

About Maravai Life Sciences

Maravai Life Sciences is a company based in San Diego (United States) founded in 2014 by Eric Tardif.. The company has 570 employees as of December 31, 2024. Maravai Life Sciences has completed 6 acquisitions, including Cygnus Technologies, Glen Research and MockV Solutions. Maravai Life Sciences offers products and services including mRNA Products, Impurity Detection Assays, and Molecular Diagnostics Tools. Maravai Life Sciences operates in a competitive market with competitors including Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.

  • Headquarter San Diego, United States
  • Employees 570 as on 31 Dec, 2024
  • Founders Eric Tardif
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Maravai Lifesciences Holdings, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $259.19 M
    -10.3
    as on Dec 31, 2024
  • Net Profit
    $-144.85 M
    -21.69
    as on Dec 31, 2024
  • EBITDA
    $-6.21 M
    -113.94
    as on Dec 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    570

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Maravai Life Sciences

Maravai Life Sciences is a publicly listed company on the NASDAQ with ticker symbol MRVI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NASDAQ · Ticker: MRVI . Sector: Health technology · USA

Products & Services of Maravai Life Sciences

Maravai Life Sciences offers a comprehensive portfolio of products and services, including mRNA Products, Impurity Detection Assays, and Molecular Diagnostics Tools. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Materials for mRNA vaccine and therapeutic development

Assays to ensure purity and safety of biopharmaceuticals

Tools for DNA and RNA synthesis in research applications

People of Maravai Life Sciences
Headcount 200-500
Employee Profiles 42
Board Members and Advisors 10
Employee Profiles
People
Pete Leddy
EVP & Chief Administrative Officer
People
Kurt Oreshack
EVP, Secretary & General Counsel
People
Robert Gillespie
Sr. Director Of Finance
People
Christine Dolan
COO, Biologics Safety Testing

Unlock access to complete

Board Members and Advisors
people
Murali K. Prahalad
Director

Unlock access to complete

Funding Insights of Maravai Life Sciences

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2018 Amount Debt – Conventional - Maravai Life Sciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Maravai Life Sciences

Maravai Life Sciences has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Cygnus Technologies, Glen Research and MockV Solutions. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Viral clearance kits are developed for biopharma manufacturing processes.
2012
Diversified nucleotides are manufactured by MyChem for biotech applications.
2007
Analytical products for life sciences are manufactured and supplied.
2003
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Maravai Life Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Maravai Life Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Maravai Life Sciences

Maravai Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of contract research and manufacturing services for both small molecules and biologics
domain founded_year HQ Location
Provider of antibody discovery, cell line development, and bio analytics services
domain founded_year HQ Location
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
domain founded_year HQ Location
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
domain founded_year HQ Location
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Maravai Life Sciences

Frequently Asked Questions about Maravai Life Sciences

When was Maravai Life Sciences founded?

Maravai Life Sciences was founded in 2014 and raised its 1st funding round 4 years after it was founded.

Where is Maravai Life Sciences located?

Maravai Life Sciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

How many employees does Maravai Life Sciences have?

As of Dec 31, 2024, the latest employee count at Maravai Life Sciences is 570.

What is the annual revenue of Maravai Life Sciences?

Annual revenue of Maravai Life Sciences is $259.19M as on Dec 31, 2024.

What does Maravai Life Sciences do?

Maravai Life Sciences was founded in 2014 and is headquartered in San Diego, United States. Operations focus on the life sciences sector, where enabling tools and services are supplied to support research and bio-production activities. These offerings include products for nucleic acid production and delivery, alongside related services for biopharmaceutical development. The company serves global clients in academic, industrial, and therapeutic applications.

Who are the top competitors of Maravai Life Sciences?

Maravai Life Sciences's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.

What products or services does Maravai Life Sciences offer?

Maravai Life Sciences offers mRNA Products, Impurity Detection Assays, and Molecular Diagnostics Tools.

Is Maravai Life Sciences publicly traded?

Yes, Maravai Life Sciences is publicly traded on NASDAQ under the ticker symbol MRVI.

How many acquisitions has Maravai Life Sciences made?

Maravai Life Sciences has made 6 acquisitions, including Cygnus Technologies, Glen Research, and MockV Solutions.

What is Maravai Life Sciences's ticker symbol?

The ticker symbol of Maravai Life Sciences is MRVI on NASDAQ.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available